Methotrexate in the treatment of peripheral arthritis in ulcerative colitis;Il methotrexate nella terapia dell'artrite periferica in corso di rettocolite ulcerosa

Reumatismo

Volumn 61, Issue 1, 2009, Pages 15-20

  Peluso, Rosario ^a   Atteno, M ^a   Iervolino, S ^a   Bruner, V ^a   Caso, F ^a   Costa, L ^a   Raimondo, M ^a   Lofrano, M ^a   Manguso, F ^a   Scarpa, R ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Arthritis; Methotrexate; Ulcerative colitis

Indexed keywords

C REACTIVE PROTEIN; MESALAZINE; METHOTREXATE; METOCLOPRAMIDE; ANTIRHEUMATIC AGENT;

ADULT; AGED; ARTHRITIS; ARTICLE; CLINICAL ARTICLE; CYTOLYSIS; DISEASE ACTIVITY; DISEASE ASSOCIATION; DOSE RESPONSE; DRUG DOSE REDUCTION; DRUG EFFICACY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FUNCTIONAL STATUS; GASTROINTESTINAL SYMPTOM; HEALTH ASSESSMENT QUESTIONNAIRE; HUMAN; MALE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; NAUSEA AND VOMITING; PERIPHERAL ARTHRITIS; POLYARTHRITIS; RITCHIE ARTICULAR INDEX; SEROLOGY; SIDE EFFECT; TREATMENT DURATION; ULCERATIVE COLITIS; VISUAL ANALOG SCALE; COMPARATIVE STUDY; EVALUATION; MIDDLE AGED; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SPONDYLOARTHROPATHY; TIME; TREATMENT OUTCOME;

ADULT; AGED; ANTIRHEUMATIC AGENTS; COLITIS, ULCERATIVE; FEMALE; HUMANS; MALE; METHOTREXATE; MIDDLE AGED; QUESTIONNAIRES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SPONDYLARTHROPATHIES; TIME FACTORS; TREATMENT OUTCOME;

EID: 66149116476     PISSN: 00487449     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Levine JB. Extraintestinal manifestation of inflammatory bowel disease. In: Kirsner JB, ed. Inflammatory bowel disease. Philadelphia: W.B. Saunders Company 2000; 397-409.
2. Scarpa R, Del Puente A, D'Arienzo A, di Girolamo C, della Valle G, Panarese A, et al. The arthritis of ulcerative colitis: clinical and genetic aspects. J Rheumatol 1992; 19: 373-7.
3. Veys EM, Mielants H. Enteropathic arthropathies. In: Klippel JH, Dieppe PA, eds. Rheumatology. London: Mosby 1998; 24: 1-8.
4. Marcolongo R. Uno sguardo al futuro: la nuova classificazione delle "malattie reumatiche". Reumatismo 1999; 51: 1-12.
5. Orchard TR, Wordsworth BP, Jewell DP. Peripheral arthropathies in inflammatory bowel disease: their articular distribution and natural history. Gut 1998; 42: 387-91.
6. Kane SV, Bjorkman DJ. The efficacy of oral 5-ASAs in the treatment of active ulcerative colitis: a systematic review. Rev Gastroenterol Disord 2003; 3: 210-8.
7. Dissanayake AS, Truelove SC. A controlled therapeutic trial of long-term maintenance treatment of ulcerative colitis with sulphazalazine (Salazopyrin). Gut 1973; 14: 923-6.
8. Schroeder KW. Role of mesalazine in acute and long-term treatment of ulcerative colitis and its complications. Scand J Gastroenterol Suppl 2002; 236: 42-7.
9. Goldstein F. Immunosuppressant therapy of inflammatory bowel disease. Pharmacologic and clinical aspects. J Clin Gastroenterol 1987; 9: 654-8.
10. Sandborn WJ. Cyclosporine therapy for inflammatory bowel disease: definitive answers and remaining questions. Gastroenterology 1995; 109: 1001-3.
11. Cummings JR, Herrlinger KR, Travis SP, Gorard DA, McIntyre AS, Jewell DP. Oral methotrexate in ulcerative colitis. Aliment Pharmacol Ther 200515; 21: 385-9.
12. Baron JH, Connell AM, Lennard-Jones JE. Variation between observers in describing mucosal appearances in proctocolitis. Br Med J 1964; 11: 89-92.
13. Truelove SC, Richards WC. Biopsy studies in ulcerative colitis. Br Med J 1956; 9: 1315-8.
14. Rachmilewitz D. Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomised trial. Br Med J 1989; 14: 82-6.
15. Dougados M, van der Linden S, Juhlin R, Huitfeldt B, Amor B, Calin A, et al. The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy. Arthritis Rheum 1991; 34: 1218-27.
16. Willkens RF, Watson MA. Methotrexate: a perspective of its use in the treatment of rheumatic diseases. J Lab Clin Med 1982; 100: 314-21.
17. Schnabel A, Gross WL. Low-dose methotrexate in rheumatic diseases efficacy, side effects, and risk factors for side effects. Semin Arthritis Rheum 1994; 23: 310-27.
18. Kristensen LE, Christensen R, Bliddal H, Geborek P, Danneskiold-Samsoe B, Saxne T. The number needed to treat for adalimumab, etanercept, and infliximab based on ACR50 response in three randomized controlled trials on established rheumatoid arthritis: a systematic literature review. Scand J Rheumatol 2007; 36: 411-7.
19. Wisłowska M, Jakubicz D. Preliminary evaluation in rheumatoid arthritis activity in patients treated with TNF-alpha blocker plus methotrexate versus methotrexate or leflunomide alone. Rheumatol Int 2007; 27: 641-7.
20. Espinoza LR, Zakraoui L, Espinoza CG, et al. Psoriatic arthritis: clinical response and side effects to methotrexate therapy. Scand J Rheumatol 1992; 19: 872-7.
21. Reveille JD, Arnett FC. Spondyloarthritis: update on pathogenesis and management. Am J Med 2005; 118: 592-603.
22. Anandarajah A, Ritchlin CT. Treatment update on spondyloarthropathy. Curr Opin Rheumatol 2005; 17: 247-56.
23. Feagan BG, Rochon J, Fedorak RN, Irvine EJ, Wild G, Sutherland L, et al. Methotrexate for the treatment of Crohn's disease. The North American Crohn's Study Group Investigators. N Engl J Med 1995; 2: 292-7.
24. Rampton DS. Methotrexate in Crohn's disease. Gut 2001; 48: 790-1.
25. Egan LJ, Sandborn WJ, Tremaine WJ, Leighton JA, Mays DC, Pike MG, et al. A randomized dose-response and pharmacokinetic study of methotrexate for refractory inflammatory Crohn's disease and ulcerative colitis. Aliment Pharmacol Ther 1999; 13: 1597-604.
26. Oren R, Arber N, Odes S, Moshkowitz M, Keter D, Pomeranz I, et al. Methotrexate in chronic active ulcerative colitis: a double-blind, randomized, Israeli multicenter trial. Gastroenterology 1996; 110: 1416-21.
27. Oren R, Moshkowitz M, Odes S, Becker S, Keter D, Pomeranz I, et al. Methotrexate in chronic active Crohn's disease: a double-blind, randomized, Israeli multicenter trial. Am J Gastroenterol 1997; 92: 2203-9.
28. Arora S, Katkov W, Cooley J, Kemp JA, Johnston DE, et al. Methotrexate in Crohn's disease: results of a randomized, double-blind, placebo-controlled trial. Hepatogastroenterology 1999; 46: 1724-9.